Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Combined oral contraceptives: health benefits beyond contraception.
Merck KGaA to try again to get approval for MS pill cladribine
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Anesthetic management of a parturient with neuromyelitis optica.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Fulminant demyelinating diseases.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
Review: the role of vitamin D in nervous system health and disease.
Orbital Doppler evaluation of blood flow velocities in optic neuritis.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
The invisible gorilla strikes again: sustained inattentional blindness in expert observers.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.
Pages
« first
‹ previous
…
223
224
225
226
227
228
229
230
231
…
next ›
last »